Protein kinase D3 is essential for prostratin-activated transcription of integrated HIV-1 provirus promoter via NF-κB signaling pathway

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wang, Huiping ^a,b   Zhu, Xinxing ^a   Zhu, Ying ^a   Liu, Jiangfang ^a   Hu, Xiangming ^a   Wang, Yu ^a   Peng, Sijia ^a   Chen, Yanheng ^a   Chen, Ruichuan ^a   Ding, Feng ^a   Liu, Runzhong ^a  

^a XIAMEN UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL ESTER DERIVATIVE; PROSTRATIN; PROTEIN KINASE D; PROTEIN KINASE D3; UNCLASSIFIED DRUG; BISINDOLYLMALEIMIDE; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; PHORBOL ESTER; PROTEIN KINASE C; PROTEIN KINASE C EPSILON; PROTEIN KINASE C NU;

ARTICLE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE SILENCING; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LUCIFERASE ASSAY; NONHUMAN; PROMOTER REGION; PROVIRUS; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRUS GENE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; PATHOGENICITY; VIRUS DNA CELL DNA INTERACTION;

GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HIV-1; HUMANS; INDOLES; MALEIMIDES; NF-KAPPA B; PHORBOL ESTERS; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; PROVIRUSES; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VIRUS INTEGRATION;

EID: 84929051778     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/968027     Document Type: Article

References (40)

1. M. Stevens, E. de Clercq, and J. Balzarini, "The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention, " Medicinal Research Reviews, vol. 26, no. 5, pp. 595-625, 2006.
2. R. F. Siliciano, "Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution, " Topics in HIV Medicine, vol. 13, no. 3, pp. 96-100, 2005.
3. M. Tyagi and M. Bukrinsky, "Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication, "Molecular Medicine, vol. 18, no. 7, pp. 1096-1098, 2012.
4. C. Katlama, S. G. Deeks, B. Autran, et al., "Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs, " The Lancet, vol. 381, no. 9883, pp. 2109-2117, 2013.
5. M. Sgarbanti and A. Battistini, "Therapeutics for HIV-1 reactivation from latency, " Current Opinion in Virology, vol. 3, no. 4, pp. 394-401, 2013.
6. J. Kulkosky, D. M. Culnan, J. Roman, et al., "Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART, " Blood, vol. 98, no. 10, pp. 3006-3015, 2001.
7. Y. D. Korin, D. G. Brooks, S. Brown, A. Korotzer, and J. A. Zack, "Effects of prostratin on T-cell activation and human immunodeficiency virus latency, " Journal ofVirology, vol. 76, no. 16, pp. 8118-8123, 2002.
8. G. Sánchez-Duffhues, M. Q. Vo, O. Pérez, et al., "Activation of latent HIV-1 expression by protein kinase C agonists. a novel therapeutic approach to eradicate HIV 1 reservoirs, " Current Drug Targets, vol. 12, no. 3, pp. 348-356, 2011.
9. E. J. Beans, D. Fournogerakis, C. Gauntlett, et al., "Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 29, pp. 11698-11703, 2013.
10. S. A. Williams, L.-F. Chen, H. Kwon, et al., "Prostratin antagonizes HIV latency by activating NF-κB, " Journal of Biological Chemistry, vol. 279, no. 40, pp. 42008-42017, 2004.
11. S. Sturany, J. van Lint, A. Gilchrist, J. R. Vandenheede, G. Adler, and T. Seufferlein, "Mechanism of activation of protein kinase D2(PKD2) by theCCKB/gastrin Receptor, " Journal of Biological Chemistry, vol. 277, no. 33, pp. 29431-29436, 2002.
12. O. Rey, J. Yuan, S. H. Young, and E. Rozengurt, "Protein kinase Cv/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G proteincoupled receptor agonists, " Journal of Biological Chemistry, vol. 278, no. 26, pp. 23773-23785, 2003.
13. J. L. Zugaza, J. Sinnett-Smith, J. van Lint, and E. Rozengurt, "Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway, " The EMBO Journal, vol. 15, no. 22, pp. 6220-6230, 1996.
14. F.-J. Johannes, J. Prestle, S. Eis, P. Oberhagemann, and K. Pfizenmaier, "PKCu is a novel, atypical member of the protein kinase C family, " Journal of Biological Chemistry, vol. 269, no. 8, pp. 6140-6148, 1994.
15. E. Rozengurt, O. Rey, and R. T. Waldron, "Protein kinase D signaling, " Journal of Biological Chemistry, vol. 280, no. 14, pp. 13205-13208, 2005.
16. Q. J. Wang, "PKD at the crossroads of DAG and PKC signaling, " Trends in Pharmacological Sciences, vol. 27, no. 6, pp. 317-323, 2006.
17. J. Yuan, O. Rey, and E. Rozengurt, "Activation of protein kinase D3 by signaling through Rac and the subunits of the heterotrimeric G proteins G12 and G13, " Cellular Signalling, vol. 18, no. 7, pp. 1051-1062, 2006.
18. S. A. Matthews, R. Dayalu, L. J. Thompson, and A. M. Scharenberg, "Regulation of protein kinase C by the B-cell antigen receptor, " Journal of Biological Chemistry, vol. 278, no. 11, pp. 9086-9091, 2003.
19. S. A. Matthews, P. Liu, M. Spitaler, et al., "Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes, " Molecular and Cellular Biology, vol. 26, no. 4, pp. 1569-1577, 2006.
20. B. Huang, X.-D. Yang, M.-M. Zhou, K. Ozato, and L.-F. Chen, "Brd4 coactivates transcriptional activation of NF-κB via specific binding to acetylated RelA, " Molecular and Cellular Biology, vol. 29, no. 5, pp. 1375-1387, 2009.
21. N. Ai, X. Hu, F. Ding, et al., "Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation, " Nucleic Acids Research, vol. 39, no. 22, pp. 9592-9604, 2011.
22. H. Wang, N. Zhou, F. Ding, et al., "An efficient approach for site-directed mutagenesis using central overlapping primers, " Analytical Biochemistry, vol. 418, no. 2, pp. 304-306, 2011.
23. S. E. Reed, E. M. Staley, J. P. Mayginnes, D. J. Pintel, and G. E. Tullis, "Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors, " Journal of Virological Methods, vol. 138, no. 1-2, pp. 85-98, 2006.
24. R. Pearson, K. K. Young, J. Hokello, et al., "Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency, " Journal of Virology, vol. 82, no. 24, pp. 12291-12303, 2008.
25. R. Chen, M. Liu, H. Li, et al., "PP2B and PP1 cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling, " Genes and Development, vol. 22, no. 10, pp. 1356-1368, 2008.
26. Z. Yang, Q. Zhu, K. Luo, and Q. Zhou, "The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription, " Nature, vol. 414, no. 6861, pp. 317-322, 2001.
27. Y. Han, M. Wind-Rotolo, H.-C. Yang, J. D. Siliciano, and R. F. Siliciano, "Experimental approaches to the study of HIV-1 latency, " Nature Reviews Microbiology, vol. 5, no. 2, pp. 95-106, 2007.
28. R. T. Waldron and E. Rozengurt, "Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain, " Journal of Biological Chemistry, vol. 278, no. 1, pp. 154-163, 2003.
29. M. Gschwendt, S. Dieterich, J. Rennecke, W. Kittstein, H.-J. Mueller, and F.-J. Johannes, "Inhibition of protein kinase C μ by various inhibitors. Differentiation from protein kinase c isoenzymes, " FEBS Letters, vol. 392, no. 2, pp. 77-80, 1996.
30. G. Martiny-Baron, M. G. Kazanietz, H. Mischak, et al., "Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976, " Journal of Biological Chemistry, vol. 268, no. 13, pp. 9194-9197, 1993.
31. H. Mellor and P. J. Parker, "The extended protein kinase C superfamily, " Biochemical Journal, vol. 332, part 2, pp. 281-292, 1998.
32. T. Mihailovic, M. Marx, A. Auer, et al., "Protein kinase D2 mediates activation of nuclear factor κB by Bcr-Abl in Bcr-Abl+ humanmyeloid leukemia cells, " Cancer Research, vol. 64, no. 24, pp. 8939-8944, 2004.
33. P. Storz, H. Döppler, and A. Toker, "Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor κB, " Molecular Pharmacology, vol. 66, no. 4, pp. 870-879, 2004.
34. Z. Zou, F. Zeng, W. Xu, et al., "PKD2 andPKD3promoteprostate cancer cell invasion by modulating NF-κB-and HDAC1-mediated expression and activation of uPA, " Journal of Cell Science, vol. 125, part 20, pp. 4800-4811, 2012.
35. J. W. Pierce, R. Schoenleber, G. Jesmok, et al., "Novel inhibitors of cytokine-induced IκB phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo, " Journal of Biological Chemistry, vol. 272, no. 34, pp. 21096-21103, 1997.
36. L. Sánchez-Ruiloba, N. Cabrera-Poch, M. Rodríguez-Martínez, et al., "Protein kinase D intracellular localization and activity control kinase D-interacting substrate of 220-kDa traffic through a postsynaptic density-95/discs large/zonula occludens-1-binding motif, " Journal of Biological Chemistry, vol. 281, no. 27, pp. 18888-18900, 2006.
37. L. A. Chen, J. Li, S. R. Silva, et al., "PKD3 is the predominant protein kinase D isoform in mouse exocrine pancreas and promotes hormone-induced amylase secretion, " Journal of Biological Chemistry, vol. 284, no. 4, pp. 2459-2471, 2009.
38. R. Papazyan, E. Rozengurt, and O. Rey, "The C-terminal tail of protein kinase D2 and protein kinase D3 regulates their intracellular distribution, " Biochemical and Biophysical Research Communications, vol. 342, no. 3, pp. 685-689, 2006.
39. O. Rey, R. Papazyan, R. T. Waldron, et al., "The nuclear import of protein kinase D3 requires its catalytic activity, " Journal of Biological Chemistry, vol. 281, no. 8, pp. 5149-5157, 2006.
40. P. Storz and A. Toker, "Protein kinase D mediates a stressinduced NF-κB activation and survival pathway, " The EMBO Journal, vol. 22, no. 1, pp. 109-120, 2003.